Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000548.5(TSC2):c.2009C>A(p.Pro670His) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P670L) has been classified as Benign.
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The p.P670H variant (also known as c.2009C>A), located in coding exon 18 of the TSC2 gene, results from a C to A substitution at nucleotide position 2009. The proline at codon 670 is replaced by histidine, an amino acid with similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -
Loss of glycosylation at P670 (P = 0.0044);Loss of glycosylation at P670 (P = 0.0044);Loss of glycosylation at P670 (P = 0.0044);.;Loss of glycosylation at P670 (P = 0.0044);Loss of glycosylation at P670 (P = 0.0044);Loss of glycosylation at P670 (P = 0.0044);Loss of glycosylation at P670 (P = 0.0044);.;Loss of glycosylation at P670 (P = 0.0044);Loss of glycosylation at P670 (P = 0.0044);Loss of glycosylation at P670 (P = 0.0044);Loss of glycosylation at P670 (P = 0.0044);Loss of glycosylation at P670 (P = 0.0044);.;